ZORAN ZDRAVESKI

CIK 1741285 · See Remarks · last filed 2026-01-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.3K

Companies

2

Total Filings

16

Lifetime Open-Market Net

-$1.30M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TCRX See Remarks 4,716 $0.91 $4.3K -$916.9K 9 2026-01-22
Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted See Remarks 140,092 $11.19 $1.57M -$386.9K 7 2021-02-16

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-02-12 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) $0 EDGAR
2019-12-30 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Mixed −7,082 -$147.5K EDGAR
2019-12-26 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Sell (S) −4,181 -$67.0K EDGAR
2019-12-26 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Sell (S) −7,902 -$126.4K EDGAR
2019-02-07 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) $0 EDGAR
2018-06-27 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Conv (C) +4,643 $0 EDGAR
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.